Loading...
Activity of a selective inhibitor of nuclear export, selinexor (KPT-330), against AML-initiating cells engrafted into immunosuppressed NSG mice
Currently available combination chemotherapy for acute myeloid leukemia (AML) often fails to result in long-term remissions, emphasizing the need for novel therapeutic strategies. We reasoned that targeted inhibition of a prominent nuclear exporter, XPO1/CRM1, could eradicate self-renewing leukemia-...
Na minha lista:
| Udgivet i: | Leukemia |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4994896/ https://ncbi.nlm.nih.gov/pubmed/26202935 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2015.194 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|